FDA-approved semaglutide products; labels read November 8, 2026 (Wegovy revised 06/2026; Ozempic injection SPL June 2026; Rybelsus/Ozempic tablets revised 1/2026)
ProductFormDose rangeApproved for
WegovyWeekly injection0.25 to 2.4 mgWeight management, CV risk reduction, MASH with fibrosis
Wegovy HDWeekly injection7.2 mgAdult weight management after 2.4 mg
Wegovy pillDaily tablet1.5 to 25 mgWeight management, CV risk reduction
OzempicWeekly injection0.25 to 2 mgType 2 diabetes; CV and kidney risk in type 2 diabetes
Ozempic tabletsDaily tablet1.5 to 9 mgType 2 diabetes; CV risk in high-risk type 2 diabetes
RybelsusDaily tablet3 to 14 mgType 2 diabetes; CV risk in high-risk type 2 diabetes

The milligram numbers are not interchangeable across products. A 1 mg Ozempic dose, a 1 mg Wegovy step and a 9 mg tablet are different exposures, and the labels give their own switching rules. Product-level detail lives on the Wegovy and Ozempic pages.

How does semaglutide work?

Semaglutide is a modified version of GLP-1, a gut hormone. The labels describe it as a GLP-1 analogue with 94% sequence similarity to human GLP-1 that binds and activates the GLP-1 receptor. Binding to albumin in the blood slows its clearance, which is what makes once-weekly injection possible.

In type 2 diabetes, the Ozempic label says semaglutide raises insulin release and lowers glucagon, both only when blood sugar is high, with a minor delay in stomach emptying after meals. For weight, the Wegovy label points to appetite: GLP-1 receptors sit in brain areas that regulate food intake, and in animal studies semaglutide reached and activated those neurons.

The labels also say semaglutide delays stomach emptying, and stomach and bowel effects are the most common side effects, especially early. That is why every semaglutide product starts at a low dose and steps up. How semaglutide lowers cardiovascular or kidney risk has not been established, per the labels.

What did STEP-1 and SELECT show?

STEP-1 tested weight; SELECT tested heart outcomes. Both used the 2.4 mg weekly injection, now sold as Wegovy.

Trial averages are not a forecast for any one person. Our STEP trial summary covers the other STEP studies.

How much does compounded semaglutide cost without insurance?

Across 23 compounded semaglutide programs in our price table, the lowest all-in monthly figure per program ranged from $39 to $249, with a median of $99.

"All-in" means membership fees are folded in (an annual fee divided by 12), at a standard injectable dose. The reads are first-party, from each program's own pages, dated October 15, 2026, except NexLife's, dated November 6, 2026. Many of the figures near the bottom of the range depend on a sale, a prepaid term or a membership. Programs that print no compounded price, such as Henry Meds, Hims & Hers and Ro, are excluded. The full list is in the compounded GLP-1 price index.

For comparison, NovoCare's self-pay price for brand Wegovy, read November 8, 2026, was $349 a month at 0.25 mg to 2.4 mg, $399 for Wegovy HD, and $149 to $299 for the pill.

Is compounded semaglutide legal and FDA-approved?

It is not FDA-approved. FDA's page on unapproved GLP-1 drugs, current as of October 1, 2026, says compounded drugs are not reviewed for safety, effectiveness or quality before they reach the market.

Compounded semaglutide is made with the drug in Wegovy, but it is not the same product. A state-licensed 503A pharmacy can compound it for an individual prescription. Larger-scale 503B outsourcing depends on FDA's bulks list, and FDA proposed on April 30, 2026 not to place semaglutide, tirzepatide or liraglutide on that list. The comment period was extended to July 30, 2026, and we found no final decision as of November 20, 2026.

Salt forms. FDA says some semaglutide sold by compounders may be a salt form, such as semaglutide sodium or semaglutide acetate. FDA calls these "different active ingredients" and says it is "not aware of any lawful basis for their use in compounding." Ask the pharmacy which form it uses.

FDA's page also tells people using compounded multi-dose vials to discard each vial within 28 days of first use, even if medication remains. A warning letter FDA posted on September 22, 2026 to Empower Pharmacy said its compounded semaglutide with cyanocobalamin appeared to be essentially a copy of an FDA-approved semaglutide product.

What should you check before buying compounded semaglutide?

Start with what you can verify, not what a landing page promises.

  1. The pharmacy's name and state license, which you can look up.
  2. Whether the product is semaglutide base or a salt form.
  3. The all-in monthly price, including any membership, at the dose you will actually reach.
  4. Written cancellation and refund terms, and how refills are billed.
  5. The vial size and the 28-day discard rule, so you are not paying for medicine you throw away.

Our compounded semaglutide safety checklist expands on each point.

Frequently asked questions

Is semaglutide the same as Ozempic?

Semaglutide is the molecule; Ozempic is one brand of it. Novo Nordisk sells semaglutide as Ozempic injection and tablets and as Rybelsus for type 2 diabetes, and as Wegovy injection, Wegovy HD and the Wegovy pill for weight management and heart risk. Doses and labels differ by brand. Compounded semaglutide is a separate, non-FDA-approved product.

How much weight did people lose on semaglutide in trials?

In STEP-1, adults without diabetes taking 2.4 mg weekly lost a mean 14.9% of body weight at 68 weeks, versus 2.4% on placebo. In the Wegovy label's 72-week Study 8, the 7.2 mg dose produced 18.8% versus 3.9% on placebo. These are trial averages that included lifestyle counseling; individual results varied widely and are not guaranteed.

What is the median price of compounded semaglutide?

Across the 23 compounded semaglutide programs in our price table, the median of each program's lowest all-in monthly price was $99, within a range of $39 to $249. Those are first-party reads dated October 15, 2026, with NexLife's dated November 6, 2026. Low figures often depend on sales, prepaid terms or memberships.

Why does FDA warn about semaglutide sodium?

FDA's page on unapproved GLP-1 drugs, current as of October 1, 2026, says some compounders may sell semaglutide salt forms such as semaglutide sodium or acetate. FDA calls these different active ingredients from the semaglutide in approved products and says it knows of no lawful basis for compounding with them. Ask any pharmacy which form it dispenses.

Does semaglutide reduce heart attack risk?

In people with heart disease and overweight or obesity but no diabetes, the SELECT trial found 2.4 mg weekly lowered the rate of cardiovascular death, heart attack or stroke from 8.0% to 6.5% over about 40 months, a hazard ratio of 0.80. Wegovy is FDA-approved for that use. Ozempic carries a related indication for adults with type 2 diabetes and heart disease.

Sources

  1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med 2021;384:989-1002 — published March 18, 2021; abstract read 2026-11-08
  2. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med 2023;389:2221-2232 — published December 14, 2023; abstract read 2026-11-08
  3. FDA: FDA's concerns with unapproved GLP-1 drugs used for weight loss — content current as of 10/01/2026; salt-form and 28-day statements read 2026-11-08
  4. FDA labels (DailyMed): Wegovy; Ozempic; Rybelsus and Ozempic tablets — Wegovy revised 06/2026; Ozempic highlights 01/2025 (SPL June 1, 2026); tablets revised 1/2026; read 2026-11-08
  5. FDA: Warning letter 738238, Empower Clinic Services, LLC dba Empower Pharmacy — dated 2026-09-18, posted 2026-09-22 (facts file)
  6. FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list — announced 2026-04-30 (91 FR 23431); comment period extended to 2026-07-30 (91 FR 38719); no final decision found as of 2026-10-15
  7. NovoCare: Wegovy self-pay pricing — read 2026-11-08

Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.

Check NexLife's plans and state availability → See the price index

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.